ALBANY — Lilly Phillips began her college career as the lone freshman starter on a veteran-laden University at Albany women’s basketball team that won an America East Conference championship.

Eli Lilly's GLP-1 weight-loss drugs Mounjaro and Zepbound have been removed from the Food and Drug Administration's (FDA) shortage list.Yahoo Finance Senior Health Reporter Anjalee Khemlani ...

Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S. Food and Drug Administration (FDA) that competitor Eli Lilly’s obesity and diabetes drugs are no longer ...

The Food Standards Agency has released a report which showed that more than 40 per cent of burgers and chicken tested were not compliant with food regulations. The shocking results revealed that ...

According to contemporary economic theory, a supply shock creates a material shift in the aggregate supply curve and forces prices to scramble toward a new equilibrium level. The impact of a ...

The years following China’s entry into the WTO came to be known as the “China shock” as inexpensive Chinese goods, backed by abundant labour, flooded global markets, resulting in manufacturing job ...

Eli Lilly’s two weight loss drugs have become blockbusters, bringing in more than $1 billion in annual revenue. Demand is growing in this market, but so is competition. These players ...

Donanemab, manufactured by Eli Lilly (LLY), is the latest in a new class of anti-amyloid drugs that deliver antibodies to target beta-amyloid, a protein linked to Alzheimer's disease. Initially ...

The most recent trading session ended with Eli Lilly (LLY) standing at $909.32, reflecting a -1.65% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.4%.

The shocks were not real, but participants thought they were. The majority of participants proceeded to shock learners despite hearing screams of apparent agony. Under the experimenter’s ...

Novo Nordisk and Eli Lilly are expected to rule the obesity market for a few more years without much challenge. To ensure they stay there as competition enters, the companies are spending billions in ...